CClinicalTrials.gg
CompletedNCT00615979Updated Jan 27, 2017

Far Forward Battlefield Telemedicine: Evaluation of Handheld Ultrasound

An observational study in Thoracic Injuries, sponsored by The Cleveland Clinic. Completed. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-27.

Sponsored by The Cleveland Clinic · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The goal of this study is to improve survival of battlefield trauma through ultrasound telemedicine and remotely guided therapeutics.

Read the detailed description

Specific aims to meet to improve the survival of battlefield trauma are 1)validation of portable ultrasound for diagnosis of various medical and surgical emergencies, ie cardiac tamponade, intraabdominal hemorrhage, 2)Extension of our expertise in digital echocardiography and local telemedicine to support other centers in such procedures as TEE 3)development of wireless telemedicine systems for rapid relay of ultrasonic images from portable ultrasound system to a remote review station. 4)development of a precision guide for diagnostic and therapeutic percutaneous procedures using ultrasound guidance 5)combining wireless telemetry with the guided percutaneous access tool to permit remotely guided emergency procedures 6)augmenting this work(2D/echo) with 3D/echo.

02

Conditions studied

  • Thoracic Injuries

Browse trials for

Keywords

  • trauma
  • portable ultrasound
  • telemedicine
  • Department of Defense
03

In context

Thoracic Injuries

84 studies on the registry are indexed under Thoracic Injuries; 23 are open to participants now.

This study's enrollment of 120 is below the median of 140 across 32 observational studies indexed under Thoracic Injuries.

Browse Thoracic Injuries studies →

Lead sponsor

The Cleveland Clinic is the lead sponsor of 818 studies on the registry; 118 are open to participants now.

Of its 89 completed or terminated interventional studies of FDA-regulated products, 72 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients scheduled for clinical echocardiographic study Patients with possible diagnosis of cardiac tamponade

Inclusion criteria

  • 18-80 yrs old
  • Scheduled for clinical echocardiogram

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
120 participants (actual)

Groups and cohorts

  • Miniature echo machine

    Diagnostic capabilities Wireless transfer

    Device: Miniature echo machine

Interventions

  • DeviceMiniature echo machine

    Images captured and real-time and store-and-forward file transfers performed

06

What researchers measure

Primary outcomes

  1. Validation of small portable ultrasound units

    paired t-testing and linear regression will be used to test the hypothesis that the small system is equivalent to the full-featured one (mean difference in values not different from 0 and slope of the regression line not different

    Time frame: single time point

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00615979
Lead sponsor
The Cleveland Clinic
Collaborators
United States Department of Defense
Responsible party
Sponsor
First posted
Feb 14, 2008
Start date
Oct 2002
Primary completion
Dec 2008
Completion
May 2009
Last update
Jan 27, 2017

Study contacts

James Thomas, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion